fto介导的KCTD11 RNA低甲基化促进非小细胞肺癌的进展

IF 1.6 4区 医学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Xin Liu, Bing Bai, Li Wei, Zhengchang Song
{"title":"fto介导的KCTD11 RNA低甲基化促进非小细胞肺癌的进展","authors":"Xin Liu, Bing Bai, Li Wei, Zhengchang Song","doi":"10.1615/CritRevEukaryotGeneExpr.2025059017","DOIUrl":null,"url":null,"abstract":"<p><p>N6-methyladenosine (m6A) plays a role in tumorigenesis of lung cancer (NSCLC); FTO functions as an oncogene in various cancers. However, the molecular mechanism underlying FTO-promoted lung cancer progression is still unclear. Gene expression was detected using RT-qPCR, western blot, and immunohistochemistry. The behaviors of lung cancer cells were detected using CCK-8, colony formation assay, and transwell assays. MeRIP and luciferase assays were conducted to FTO-mediated RNA hypomethylation. In vivo assays were performed to verify the roles of FTO in NSCLC. High levels of FTO in NSCLC patients predicted poor outcomes. However, FTO knockdown suppressed the proliferation and migration of A549 cells. Mechanically, FTO downregulated KCTD11 expression through promoting the RNA hypomethylation of KCTD11, the expression of which was decreased in NSCLC. KCTD11 knockdown attenuated the effects of FTO and promoted the malignancy of lung cancer. In summary, FTO functions as an oncogene in NSCLC via downregulating KCTD11. Therefore, FTO/KCTD11 can be a novel target for NSCLC.</p>","PeriodicalId":56317,"journal":{"name":"Critical Reviews in Eukaryotic Gene Expression","volume":"35 6","pages":"15-25"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"FTO-Mediated RNA Hypomethylation of KCTD11 Promotes the Progression of Non-Small Cell Lung Cancer.\",\"authors\":\"Xin Liu, Bing Bai, Li Wei, Zhengchang Song\",\"doi\":\"10.1615/CritRevEukaryotGeneExpr.2025059017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>N6-methyladenosine (m6A) plays a role in tumorigenesis of lung cancer (NSCLC); FTO functions as an oncogene in various cancers. However, the molecular mechanism underlying FTO-promoted lung cancer progression is still unclear. Gene expression was detected using RT-qPCR, western blot, and immunohistochemistry. The behaviors of lung cancer cells were detected using CCK-8, colony formation assay, and transwell assays. MeRIP and luciferase assays were conducted to FTO-mediated RNA hypomethylation. In vivo assays were performed to verify the roles of FTO in NSCLC. High levels of FTO in NSCLC patients predicted poor outcomes. However, FTO knockdown suppressed the proliferation and migration of A549 cells. Mechanically, FTO downregulated KCTD11 expression through promoting the RNA hypomethylation of KCTD11, the expression of which was decreased in NSCLC. KCTD11 knockdown attenuated the effects of FTO and promoted the malignancy of lung cancer. In summary, FTO functions as an oncogene in NSCLC via downregulating KCTD11. Therefore, FTO/KCTD11 can be a novel target for NSCLC.</p>\",\"PeriodicalId\":56317,\"journal\":{\"name\":\"Critical Reviews in Eukaryotic Gene Expression\",\"volume\":\"35 6\",\"pages\":\"15-25\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Reviews in Eukaryotic Gene Expression\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1615/CritRevEukaryotGeneExpr.2025059017\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Reviews in Eukaryotic Gene Expression","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1615/CritRevEukaryotGeneExpr.2025059017","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

n6 -甲基腺苷(m6A)在肺癌(NSCLC)发生中的作用FTO在多种癌症中起致癌基因的作用。然而,fto促进肺癌进展的分子机制尚不清楚。采用RT-qPCR、western blot和免疫组织化学检测基因表达。采用CCK-8法、集落形成法和transwell法检测肺癌细胞的行为。MeRIP和荧光素酶检测fto介导的RNA低甲基化。通过体内实验验证FTO在NSCLC中的作用。非小细胞肺癌患者中FTO水平高预示预后不良。而FTO敲除抑制了A549细胞的增殖和迁移。机制上,FTO通过促进KCTD11的RNA低甲基化来下调KCTD11的表达,而KCTD11在NSCLC中的表达降低。KCTD11敲低可减弱FTO的作用,促进肺癌的恶性发展。综上所述,FTO通过下调KCTD11在NSCLC中发挥致癌基因的作用。因此,FTO/KCTD11可能成为NSCLC的新靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
FTO-Mediated RNA Hypomethylation of KCTD11 Promotes the Progression of Non-Small Cell Lung Cancer.

N6-methyladenosine (m6A) plays a role in tumorigenesis of lung cancer (NSCLC); FTO functions as an oncogene in various cancers. However, the molecular mechanism underlying FTO-promoted lung cancer progression is still unclear. Gene expression was detected using RT-qPCR, western blot, and immunohistochemistry. The behaviors of lung cancer cells were detected using CCK-8, colony formation assay, and transwell assays. MeRIP and luciferase assays were conducted to FTO-mediated RNA hypomethylation. In vivo assays were performed to verify the roles of FTO in NSCLC. High levels of FTO in NSCLC patients predicted poor outcomes. However, FTO knockdown suppressed the proliferation and migration of A549 cells. Mechanically, FTO downregulated KCTD11 expression through promoting the RNA hypomethylation of KCTD11, the expression of which was decreased in NSCLC. KCTD11 knockdown attenuated the effects of FTO and promoted the malignancy of lung cancer. In summary, FTO functions as an oncogene in NSCLC via downregulating KCTD11. Therefore, FTO/KCTD11 can be a novel target for NSCLC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Critical Reviews in Eukaryotic Gene Expression
Critical Reviews in Eukaryotic Gene Expression 生物-生物工程与应用微生物
CiteScore
2.70
自引率
0.00%
发文量
67
审稿时长
1 months
期刊介绍: Critical ReviewsTM in Eukaryotic Gene Expression presents timely concepts and experimental approaches that are contributing to rapid advances in our mechanistic understanding of gene regulation, organization, and structure within the contexts of biological control and the diagnosis/treatment of disease. The journal provides in-depth critical reviews, on well-defined topics of immediate interest, written by recognized specialists in the field. Extensive literature citations provide a comprehensive information resource. Reviews are developed from an historical perspective and suggest directions that can be anticipated. Strengths as well as limitations of methodologies and experimental strategies are considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信